Picture of Evotec SE logo

EVT — Evotec SE News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapNeutral

Brief: Evotec Outlook FY Revenue Eur 840-880 Mln

April 17 (Reuters) - EVOTEC SE EVTG.DE:

OUTLOOK FY REVENUE EUR 840-880 MILLION

OUTLOOK FY ADJUSTED EBITDA EUR 30-50 MILLION

2025 GUIDANCE: GROUP REVENUES TO GROW 5 - 10 % (EUR 840 - 880 M)

2025 GUIDANCE: GROUP REVENUES TO GROW 5-10% (€840-880 MILLION)

2028 OUTLOOK FORESEES REVENUE CAGR2024-2028 BETWEEN 8 - 12% AND GENERATION OF EBITDA MARGIN ABOVE 20 %

2028 OUTLOOK: REVENUE CAGR 8-12%, EBITDA MARGIN ABOVE 20%

FY GROUP REVENUES INCREASED BY 2 % TO EUR 797.0 M (2023: EUR 781.4 M)

Q4 2024 REVENUES INCREASED BY 10 % TO EUR 221.2 M FROM EUR 201.3 M IN Q4 2023

FY ADJUSTED GROUP EBITDA TOTALLED EUR 22.6 M (2023: EUR 66.4 M)

TARIFFS & US GOVERNMENT FUNDING DEVELOPMENT ARE EXPECTED TO HAVE A LIMITED IMPACT ON EVOTEC'S BUSINESS

OUTLOOK 2025 ADJUSTED GROUP EBITDA IS EXPECTED TO REACH EUR 30 - 50 M (2024: EUR 22.6 M)

OUTLOOK 2025 RESEARCH AND DEVELOPMENT EXPENDITURES ARE EXPECTED IN A RANGE OF EUR 40 - 50 M (2024: EUR 50.8 M)

Source text: ID:nEQ1mTZnYa

Further company coverage: EVTG.DE

 (Gdansk Newsroom)

 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Evotec SE

See all news